From August 27, 2012 to November 25, 2012, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,132,892 shares, representing 4.29% for $6.18 million under the buyback announced on July 14, 2010.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.89 USD | -5.05% | -13.14% | -21.00% |
06-11 | 22NW Fund Submits Shareholder Proposals to Lifecore Biomedical | CI |
05-20 | 22NW Fund Nominates Candidates to the Board of Lifecore Biomedical | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.00% | 149M | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- LFCR Stock
- News Lifecore Biomedical, Inc.
- Tranche Update on Landec Corp.'s Equity Buyback Plan announced on July 14, 2010.